ISPUB.com / IJGE/10/1/10557
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Gastroenterology
  • Volume 10
  • Number 1

Original Article

Xanthogranulomatous Cholecystitis – Our Experience

F Huda, D Sah, S Awasthi, K Singh

Citation

F Huda, D Sah, S Awasthi, K Singh. Xanthogranulomatous Cholecystitis – Our Experience. The Internet Journal of Gastroenterology. 2009 Volume 10 Number 1.

Abstract

Background. Xanthogranulomatous cholecystitis (XGC) is a rare inflammatory disease of the gall bladder and mimics gall bladder carcinoma both macroscopically and histologically. This retrospective study has been undertaken to analyse the clinical as well as the surgical profiles of all the histologically proven cases of Xanthogranulomatous cholecystitis in an effort to contribute towards better understanding of this histopathological entity. Methods. All the in-patient records of patients, who had undergone cholecystectomy and were proven to have Xathogranulomatous cholecystitis between May 2008 & May 2009, were analysed retrospectively. Results: The incidence of XGC was 11.1% with 2 males and 8 females and the mean age of presentation was 43.8 years.Biliary colic was present in all the10 cases and 4 had acute illness. Ultrasonographically, all patients had gall bladder wall thickening with associated cholilithiasis. Operative difficulty was encountered in all cases because of dense adhesions and partial cholecystectomy had to be done in 2. Post operative period was uneventfull in 9 cases .1 patient developed jaundice on 7th postop day and was treated with endoscopic retrograde cholangiopancreatography.

 

Introduction

Xanthogranulomatous cholecystitis (XGC) is a rare inflammatory disease of the gallbladder characterized by a focal or diffuse destructive inflammatory process, with accumulation of lipid laden macrophages, fibrous tissue, and acute and chronic inflammatory cells. 1

Christensen and Ishak first coined the pathologic diagnosis of XGC in 1970. 2

Many pseudonyms such as ceroid granulomas, ceroid-like histiocytosis, and fibroxanthogranulomatous inflammation existed before the Armed Forces Institute of Pathology formally characterized XGC. 3

The importance of this condition lies in the fact that it may mimic a gallbladder carcinoma macroscopically and may be difficult to distinguish from malignancy even on histopathologic examination.

In this study, 10 cases of histopathologically proven Xanthogranulomatous Cholecystitis have been reviewed.

Aims and Objectives

All cases with histopathologically proven Xanthogranulomatous Cholecystitis have been reviewed in this study in an effort to contribute towards better understanding of this histopathological entity.

Materials and Methods

All the in-patient records of patients, who had undergone cholecystectomy between May 2008 and May 2009 in the Department of General Surgery ,Teerthankar Mahaveer Medical College, Moradabad (U.P.) were analysed retrospectively. Histopathological records of the excised gallbladder specimens of all these cases were then scrutinised. A total of 90 cholecystectomies were done during this time period and out of them, 10 cases (11.1%) were histopathologically proven to have Xanthogranulomatous Cholecystitis. All these 10 cases were studied in detail with respect to their clinical profile, pre-operative investigations , the surgical procedure and the post operative phase.

Observations

Incidence

Total 90 cholecystectomies were done during the study time period and out of them, 10 cases were histopathologically proven to have Xanthogranulomatous Cholecystitis (XGC) so, the incidence of XGC was 11.1% in this study.

Figure 1
MICROSCOPIC VIEW OF XGC (100X)

Figure 2
MICROSCOPIC VIEW OF XGC (400X)

Sex

There were 2 male and 8 female patients with Xanthogranulomatous cholecystitis.

Age Distribution

5 patients (50%) were older than 50years of age, 3 (30%) were between 35-45 years and 2 (20%) were < 35 years age. The mean age at presentation was 43.8 years. Individual ages were as mentioned in Table –1.

Figure 3
Table –1

Total Duration of Illness

5 (50%) patients had clinical symptoms since 15 days, 2 had symptoms since more than a month and the remaining 3 patients had symptoms for >1year.

Detailed duration of symptoms were as mentioned below (Table-2):

Figure 4
Table –2

Clinical Features

All the10 patients presented with history of biliary colic. 5 of them had associated nausea and vomiting. 4 (40%) patients presented with clinical features of Acute Cholecystitis.Other features were as mentioned below: (Table- 3)

Figure 5
Table- 3

Gall bladder wall thickening was seen in all the cases on ultrasound. The range of thickess varied from 3.6 to 6mm.

5 (50%) patients had multiple stones and 5 had a single stone in gallbladder lumen. 1 patient also had choledocholithiasis.

8 (80%) cases had atleast 1 stone measuring more than 10mm in maximum diameter while the remaining 2 patients had smaller stones.(Table-4)

Figure 6
Table- 4

Operative Procedure & Findings

All patients had dense adhesions specially over the triangle of Calot’s. Additionaly,1 case had a gall bladder perforation at the fundus and 2 had pyocoele. (Table-6)

Figure 7
Table-6

Laparoscopic cholecystectomy was done successfully in 2 cases, however the duration of procedure was more. Laparoscopic procedure was converted to open in 4 cases because of difficult dissection. 4 patients opted for open cholecystectomy by choice.

Partial cholecystectomy had to be done in 2 cases because of dense adhesions over the Calot’s triangle. Choledocholithotomy could not be done in 1 patient with choledocholithiasis because of the same reason.

Post Operative Course

The postoperative course was uneventful in 9 cases. 1 patient with peritonitis and choledocholithiasis, who underwent partial cholecystectomy, developed icterus on the 7th post op day. He underwent ERCP after which his icterus resolved and was then discharged in a satisfactory clinical state.

Discussion

Xanthogranulomatous cholecystitis is an uncommon variant of cholecystitis that is rarely diagnosed preoperatively. It is generally more virulant than ordinary cholecystitis. It appears to result from ruptured Rokitansky-Aschoff sinuses with intramural extravasation of bile and subsequent xanthogranulomatous reaction.

Incidence

The incidence of Xanthogranulomatous Cholecystitis (XGC) in our study was 11.1% (10 out of 90 cases of cholecystectomy). This figure corelates with that of a study conducted in Varanasi, India by Dixit VK 4 and colleagues, who reported the incidence to be 8.9% (41 out of 460 cholecystectomies) (Chart-1).

Similarly, Krishna RP 5 et al, Lucknow, India reported a 10% incidence of XGC (620 out of 6,150 cholecystectomies)

However, the incidence reported by Guzman-Valdivia G 6 in Regional General Hospital, Mexico, was 1.46% (182 out of 12,426 cases), similar to that reported by Karabulut Z 7 1.5% (12 out of 770 cases)

KM Roberts& MA Parsons 8, also found this incidence to be 1.8% (13 out of 724) in the University of Sheffield Medical School, Scheffield.

This difference in the incidence of XGC might be attributed to the different geographic, environmental or racial factors in studies conducted in India and in other countries.

Figure 8
CHART-1

Sex

There were 2 male and 8 female patients with XGC in our study. So, the male to female ratio was 1:4.

In other studies, the male to female ratio varies from 1:1 to 2:1 6-11 . Therefore, XGC doesn’t seem to have a predeliction to a particular sex.(Chart-2)

Figure 9
CHART-2

Age

The mean age at presentation was 43.8 years in our study (Table-1). The mean age of presentation reported in various other studies ranges from 44 to 63 years. 4, 7, 8 ,10, 11

(Chart-3)

Figure 10
CHART-3

CLINICAL PRESENTATION

Clinically, 4 (40%) patients presented with acute illness (Table-3).

In the study conducted by Karabulut Z 7 ,41.6% patients presented in acute form.

These figures are significantly higher than those reported by Guzman-Valdivia G 6 & Dixit Vk et al 4, who reported this presentation in 17% & 0% cases respectively.

Gall bladder wall thickening was the most consistent finding on ultrasonography found in all the 10 cases with thickness ranging from 3.6 to 6mm (Table-4).

The same observation has been made in various other studies like those conducted by Kim PN et al, Guzman Valdivia G & Parra JA. 6,11,12 (Chart 4)

So, finding a thickened gall bladder wall sonographically, may be helpful in the diagnosis of XGC.

Another important finding on USG was the presece of cholilithiasis in all the cases in this study. In the literature, the association of cholilithiasis with XGC varies among different studies from 54.5 to 100% . 3,6,7,9,12,13

Presence of Intramural nodules in the gall bladder on ultrasonography, has been reported as an important finding in patients with XGC by Kim PN 12 and colleagues who reported these nodules in 72.7% cases (8out of11), although, none of the cases in the present series had this finding.

Figure 11
CHART-4

Intra-Operative Findings

Intraoperatively, adhesions involving the gallbladder wall, liver and omentum were found in all the cases. (Table-6)

Perforated gall bladder was found in 1 (20%) case. PN Kim 12 and Houston JP 13 and colleagues, in seperate studies, have reported perforation in 13% of the cases.

Partial cholecystectomy was done in 2 cases (20%) primarily because of dense adhesions over the triangle of Callot’s.

In the case series reported by Srinivas GN 10, partial cholecystectomy was done in 38% cases and in those reported by Guzman Valdivia G 6, this procedure was done in 35% cases.

Therefore, patients with XGC have a high incidence of adhesions and hence a high rate of partial cholecystectomy.

Houston JP 13 and Roberts KM 8 have also reported the presence of biliary fistula in 12.9% and 23% cases respectively, in their case series. These fistulae were either communicating with the skin or with the duodenum.

Post- Operative Phase

The postoperative course was uneventful in 9 cases but 1 patient developed icterus on the 7th post op day. He underwent ERCP after which his icterus resolved and was then discharged in a satisfactory clinical state.

In the literature, however, a much higher incidence of post-op complications have been reported.

Roberts KM and Parsons MA 8 have reported post-op complications in 30.7% (4 out of 13 cases). These complications included subphrenic abscees in 1 case and wound infections in 3 cases.

Karabukut Z 7 has also reported complications in 25% (3 out of 12) cases which include wound infection, pulmonary infection and biliary peritonitis.

Conclusions

  1. Xanthogranulomatous cholecystitis is an uncommon variant of cholecystitis with incidence ranging from 1.4 to 11% (11.1% in this study).

  2. The male to female ratio varies from 1:1 to 2:1 (1:4 in the present series)so, XGC doesn’t seem to have a predeliction to a particular sex.

  3. The mean age of presentation ranges from 44 to 63 years (43.8 years in this study).

  4. Clinically, most patients present with chronic illness although upto 41.6% cases have been reported to present in the acute form.

  5. Gall bladder wall thickening is the most consistent finding on ultrasonography.

  6. Other sonographic features may include the cooexistence of cholelithiasis in most of the cases (upto 100%) and presence of intramural nodules.

  7. Operative difficulty due to extensive adhesions may be encountered in a large proportion of cases and so, partial cholecystectomy may have to be done.

  8. There is a high rate of post-operative complications as reported in the literature although most of the cases in the present case series had a smooth postoperative phase.

References

1. Jessurun, J, Albores-Saavedra, J. Gallbladder and Extrahepatic Biliary Ducts. In: Anderson's Pathology, Damjanov, I, Linder, J (Eds). CV Mosby, St. Louis 1996. p.1859.
2. Christensen AH, Ishak KG. Benign tumours and pseudotumours of the gall bladder. Archives of Pathology 1970;90:423-32.
3. Goodman ZO, Ishak KG. Xanthogranulomatous cholecystitis.Am J Surg Pathol 1981;5:653-9.
4. Dixit VK; Prakash A; Gupta A; Pandey M; Gautam A; Kumar M; Shukla VK Xanthogranulomatous cholecystitis. Dig Dis Sci 1998 May;43(5):940-2
5. Krishna RP; Kumar A; Singh RK; Sikora S; Saxena R; Kapoor VK. Xanthogranulomatous Inflammatory Strictures of Extrahepatic Biliary Tract: Presentation and Surgical Management. J Gastrointest Surg. 2008 Feb 12
6. Guzman-Valdivia G. Xanthogranulomatous cholecystitis: 15 years' experience. World J Surg 2004 Mar;28(3):254-7. Epub 2004 Feb 17
7. Karabulut Z. Xanthogranulomatous cholecystitis.Retrospective analysis of 12 cases. Acta Chir Belg - 01-JUN-2003; 103(3): 297-9.
8. Roberts K M and Parsons M A . Xanthogranulomatous cholecystitis: clinicopathological study of 13 cases. J Clin Pathol. 1987 April; 40(4): 412–417
9. Eriguchi N. Xanthogranulomatous cholecystitis. Kurume Med J - 01-JAN-2001; 48(3): 219-21
10. Srinivas GN; Sinha S; Ryley N; Houghton PW. Perfidious gallbladders - a diagnostic dilemma with xanthogranulomatous cholecystitis. Ann R Coll Surg Engl. 2007 Mar;89(2):168-72.
11. Parra JA; Acinas O; Bueno J; Guezmes A; Fernandez MA; Farinas MC. Xanthogranulomatous cholecystitis: clinical, sonographic, and CT findings in 26 patients. AJR Am J Roentgenol 2000 Apr;174(4):979-83
12. Kim P N; Ha H K; Kim Y H; Lee M G; Kim M H; Auh Y H. US findings of xanthogranulomatous cholecystitis.Clinical Radiology April 1998;53(4): 290-92.
13. Houston JP; Collins MC; Cameron I; Reed MW; Parsons MA; Roberts KM. Xanthogranulomatous cholecystitis. Br J Surg 1994 Jul;81(7):1030-2.

Author Information

F Huda
Department Of General Surgery, Teerthankar Mahaveer Medical College & Research Centre

D Sah
Department Of General Surgery, Teerthankar Mahaveer Medical College & Research Centre

S Awasthi
Department Of Pathology, Teerthankar Mahaveer Medical College & Research Centre

K Singh
Department Of General Surgery, Teerthankar Mahaveer Medical College & Research Centre

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy